Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
94.390,95
0,25%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sunesis Pharmaceuticals Inc (SNSS) Sunesis Pharmaceuticals Inc (SNSS) Notizie

SNSS

Sunesis Pharmaceuticals (SNSS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNSS
DataOraFonteTitoloSimboloCompagnia
10/06/202300:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/05/202322:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/05/202322:53Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202322:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202322:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/03/202322:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/02/202312:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/01/202323:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/11/202222:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
20/09/202200:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/202222:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/06/202222:37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/12/202112:08Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/02/202122:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
15/01/202112:24Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/01/202123:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
13/01/202112:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/11/202022:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/11/202013:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/10/202013:00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ...NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/09/202013:00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/09/202018:48GlobeNewswire Inc.Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock SplitNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/08/202022:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/08/202013:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Hi...NASDAQ:SNSSSunesis Pharmaceuticals Inc
31/07/202000:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
29/07/202015:05GlobeNewswire Inc.Sunesis Announces Pricing of $12 Million Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
28/07/202022:07GlobeNewswire Inc.Sunesis Announces Proposed Public Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/07/202022:01GlobeNewswire Inc.Sunesis Pharmaceuticals Provides Corporate UpdateNASDAQ:SNSSSunesis Pharmaceuticals Inc
23/06/202013:30GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib ProgramNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/202022:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SNSS

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SRG
Snam
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
LDO
Leonardo
BIT
PRY
Prysmian
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network